Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
CALL
Northrop Grumman
NOC
$77.1B
| $4.65M | ﹤0.01% |
29,300
-5,600
| -16% | -$897K |
|
3002
CALL
RH
RH
$3.13B
| $4.65M | ﹤0.01% |
47,600
-62,700
| -57% | -$5.78M |
|
3003
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.38B
| $4.63M | ﹤0.01% |
85,936
+31,871
| +59% | +$1.75M |
|
3004
Aegon
AEG
$14B
| $4.63M | ﹤0.01% |
889,685
+19,648
| +2% | +$107K |
|
|
NEE.PRO
3005
DELISTED
NEXTERA ENERGY INC UNITS EXPIRING 09/01/2015 (FL)
NEE.PRO
| $4.63M | ﹤0.01% |
75,018
| – | – |
|
|
AUY
3006
DELISTED
Yamana Gold, Inc.
AUY
| $4.63M | ﹤0.01% |
1,542,754
-235,347
| -13% | -$860K |
|
|
FUR
3007
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
| $4.63M | ﹤0.01% |
305,466
+62,811
| +26% | +$1.01M |
|
3008
Materion
MTRN
$4.39B
| $4.63M | ﹤0.01% |
131,202
+14,512
| +12% | +$559K |
|
3009
PUT
LyondellBasell Industries
LYB
$20B
| $4.62M | ﹤0.01% |
44,600
-4,600
| -9% | -$463K |
|
3010
PUT
Alaunos Therapeutics
TCRT
$4.59M
| $4.61M | ﹤0.01% |
2,563
+1,982
| +341% | +$3.08M |
|
|
ZNGA
3011
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $4.61M | ﹤0.01% |
1,611,777
+1,075,313
| +200% | +$3.01M |
|
|
EPE
3012
DELISTED
EP Energy Corporation
EPE
| $4.61M | ﹤0.01% |
362,015
+224,386
| +163% | +$2.98M |
|
3013
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $4.6M | ﹤0.01% |
+95,777
| New | +$4.85M |
|
3014
Genpact
G
$5.96B
| $4.59M | ﹤0.01% |
215,059
+153,538
| +250% | +$3.44M |
|
|
CDTX
3015
DELISTED
Cidara Therapeutics
CDTX
| $4.59M | ﹤0.01% |
+16,356
| New | +$5.03M |
|
|
CEB
3016
DELISTED
CEB Inc.
CEB
| $4.58M | ﹤0.01% |
52,660
+5,052
| +11% | +$429K |
|
3017
CALL
DigitalBridge
DBRG
$2.93B
| $4.58M | ﹤0.01% |
+61,950
| New | +$5.26M |
|
|
3018
PUT
DigitalBridge
DBRG
$2.93B
| $4.58M | ﹤0.01% |
+61,950
| New | +$5.26M |
|
|
CA
3019
CALL
DELISTED
CA, Inc.
CA
| $4.57M | ﹤0.01% |
156,100
-156,700
| -50% | -$4.87M |
|
3020
Aecom
ACM
$9.3B
| $4.56M | ﹤0.01% |
137,875
+28,282
| +26% | +$933K |
|
3021
CALL
State Street SPDR S&P Retail ETF
XRT
$449M
| $4.54M | ﹤0.01% |
92,000
-117,600
| -56% | -$5.85M |
|
|
LL
3022
CALL
DELISTED
LL Flooring Holdings, Inc.
LL
| $4.54M | ﹤0.01% |
219,100
-116,700
| -35% | -$3.07M |
|
3023
PUT
Cameco
CCJ
$37.6B
| $4.54M | ﹤0.01% |
317,700
+138,000
| +77% | +$2.18M |
|
|
EXAS
3024
PUT
DELISTED
Exact Sciences
EXAS
| $4.53M | ﹤0.01% |
152,300
+42,300
| +38% | +$1.06M |
|
|
P
3025
PUT
DELISTED
Pandora Media Inc
P
| $4.52M | ﹤0.01% |
291,000
+2,400
| +0.8% | +$42.1K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.